Swiss National Bank Catalyst Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$137 Billion
Q1 2025

A detailed history of Swiss National Bank transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 207,900 shares of CPRX stock, worth $5.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

207,900

Previous 210,100 1.05%

Holding current value

$5.19 Million

Previous $4.38 Million 14.99%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$19.53 - $25.74 $42,966 - $56,628	-2,200 Reduced 1.05%	207,900 $5.04 Million
Q4 2024 Feb 10, 2025	BUY	$19.73 - $23.93 $49,325 - $59,825	2,500 Added 1.2%	210,100 $4.38 Million
Q3 2024 Nov 07, 2024	SELL	$15.19 - $21.35 $18,228 - $25,620	-1,200 Reduced 0.57%	207,600 $4.13 Million
Q1 2024 May 07, 2024	BUY	$13.18 - $17.11 $259,646 - $337,067	19,700 Added 10.42%	208,800 $3.33 Million
Q4 2023 Feb 06, 2024	SELL	$11.78 - $17.29 $393,452 - $577,486	-33,400 Reduced 15.01%	189,100 $3.18 Million
Q3 2023 Nov 08, 2023	BUY	$11.69 - $15.02 $46,760 - $60,080	4,000 Added 1.83%	222,500 $2.6 Million
Q2 2023 Aug 09, 2023	BUY	$11.5 - $18.08 $58,650 - $92,207	5,100 Added 2.39%	218,500 $2.94 Million
Q1 2023 May 10, 2023	SELL	$14.34 - $21.05 $322,650 - $473,625	-22,500 Reduced 9.54%	213,400 $3.54 Million
Q4 2022 Feb 08, 2023	BUY	$12.25 - $19.5 $51,450 - $81,900	4,200 Added 1.81%	235,900 $4.39 Million
Q1 2022 May 09, 2022	BUY	$5.31 - $8.31 $75,933 - $118,833	14,300 Added 6.58%	231,700 $1.92 Million
Q2 2021 Aug 06, 2021	SELL	$4.29 - $6.05 $32,604 - $45,980	-7,600 Reduced 3.38%	217,400 $1.25 Million
Q1 2021 May 07, 2021	BUY	$3.45 - $4.69 $19,665 - $26,733	5,700 Added 2.6%	225,000 $1.04 Million
Q2 2020 Aug 05, 2020	BUY	$3.48 - $5.05 $137,112 - $198,970	39,400 Added 21.9%	219,300 $1.01 Million
Q1 2020 May 08, 2020	BUY	$2.61 - $5.21 $6,786 - $13,546	2,600 Added 1.47%	179,900 $693,000
Q4 2019 Feb 06, 2020	BUY	$3.67 - $5.7 $19,084 - $29,640	5,200 Added 3.02%	177,300 $665,000
Q2 2019 Aug 02, 2019	BUY	$2.7 - $6.11 $464,670 - $1.05 Million	172,100 New	172,100 $661,000

Others Institutions Holding CPRX

# of Institutions

388

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.57B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Catalyst Pharmaceuticals, Inc. Transaction History